PIK3C3 and cancer: These data confirmed that targeted- or chemo-therapeutic agents induce autophagy in cancer cells, which led us to hypothesize that targeting autophagy by a novel PIK3C3 inhibitor, MPT0L145 [16], might increase their sensitivity.